Lamictal TM, Haloperidol Decanoate in Schizophrenia
Status:
Terminated
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of lamotrigine augmentation of
Haloperidol decanoate in the treatment of Resistant Schizophrenia predominantly by verbal
resistant hallucinosis: A randomized, double-blind, placebo-controlled, study.
Nadir A.Aliyev & Zafar N.Aliyev
Central Mental Clinic for Outpatients of Baku city of Azerbaijan Republic
Abstract:
OBJECTIVE: The current paper reports on a double-blind, randomized study of the role of
lamotrigine as an augmentation agent to haloperidol decanoate in the treatment of out
patient's schizophrenia with verbal resistant hallucinosis.
Phase:
Phase 4
Details
Lead Sponsor:
Central Mental Clinic for Outpatients of Baku City